Back to Journals
Pharmacogenomics and Personalized Medicine
Pathology, Maimonides Medical Center, United States
Editor-in-Chief: Dr Martin H. Bluth
Dr. Bluth completed his MD and PhD (Immunology) degrees at SUNY Downstate Medical Center, residency in Clinical Pathology at Kings County Hospital, his fellowship training in Transfusion Medicine at the New York Blood Center and post-doctoral fellowship in tumor markers at the Veteran’s Affairs Medical Center in NY. He maintains board certification in his disciplines. He previously served as Chief Medical Officer for Consolidated Laboratory Management Systems, Vice President for BioMedica Corporation, Director of Pathology Laboratories for Michigan Surgical Hospital, Director of Surgical Research for SUNY Downstate Medical Center among other top tier positions. Dr Bluth currently holds appointments as Chief of Blood Transfusion Medicine and Donor Services, Assistant Director of Clinical Laboratories and Director of Translational Research for the Department of Pathology at Maimonides Medical Center, Professor of Pathology at Wayne State University School of Medicine and Global Medical Director for Kids Kicking Cancer. He also serves as Associate Editor for Henry’s Clinical Diagnosis and Management by Laboratory Methods, the premier textbook on Clinical Pathology and Laboratory Medicine, as Editor in Chief for three peer reviewed medical journals, and reviews for over a dozen other journals in various disciplines. He is a serial entrepreneur and founder of Bluth Bio Industries, LLC which provides consultation as well as facilitates and matures novel biomarkers, devices and therapeutics (www.bluthbio.com). Dr. Bluth is a leader in laboratory centric drug testing, molecular pathology and pharmacovigilance guidance and serves on numerous committees including the Michigan State Medical Society Committee on Health Care Quality, Efficiency and Economics, and consults for numerous healthcare associations as well as community and political advocacy entities. Dr. Bluth is considered an expert in his field, has authored over 250 publications, and is sought after for speaking engagements and consultation worldwide.
Hiltrud Brauch, Deputy Head, the Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
Professor of Life Sciences, Arizona State University, Barrett Honors Faculty, Arizona State University, Affiliated Scholar, ASU Healthcare Delivery and Policy Program, Professor of Laboratory Medicine and Pathology, Mayo College of Medicine, Adjunct Professor of Pathology, Johns Hopkins Medical Institutions CMO, USA.
Vicki Ellingrod, Clinical Social and Administrative Sciences, College of Pharmacy and Medicine, University of Michigan, MI, USA
Takahisa Furuta, Center for Clinical Research, Hamamatsu University School of Medicine, Hamamatsu, Japan
Jing Li, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA.
Qing Ma, Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, NY, USA
Dr Maitland-van der Zee
Anke-Hilse Maitland-van der Zee, Professor of Precision Medicine in Respiratory Diseases, Faculty of Medicine, University of Amsterdam, Netherlands.
Gene Morse, SUNY Distinguished Professor – Pharmacy Practice (Medicine, Pediatrics), University at Buffalo, NY, USA.
Wolfgang Sadee, Professor, Department of Cancer Biology and Genetics; Director, Center for Pharmacogenomics, The Ohio State University, USA; and Chief Scientific Officer, Aether Therapeutics Inc, USA.
Andrew Somogyi, Professor of Clinical and Experimental Pharmacology, University of Adelaide, Australia.
Michael A. Tainsky, Professor, Department of Oncology, Fred and Barbara Erb Endowed Professor of Cancer Genetics, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA